Related by context. All words. (Click for frequent words.) 82 XOMA 3AB biodefense 77 candidate REP# 75 botulism antibody 75 pharmacogenomic translational research 74 Initiates Phase II 74 Crofelemer budesonide foam 74 sapropterin dihydrochloride Phase 74 triggers apoptosis programmed 73 XL# anticancer compounds 73 oncolytic virus therapies 73 AAG geldanamycin analog 73 include Phenoptin TM 73 Begins Dosing 73 thrombin component 73 Initiates Clinical Trial 72 Submits Biologics License Application 72 Files IND 72 neuropathic pain metabolic diseases 72 Pruvel TM 72 targeted radiotherapeutic 72 molecular therapeutics immunotherapies 72 Initiates Enrollment 72 fibrosis IPF 71 commercialize CorMedix drug 71 pralatrexate injection folate analogue 71 Alfacell proprietary ribonuclease 71 infectious diseases autoimmune 71 non nucleoside inhibitor 71 addressing idiopathic pulmonary 71 semi synthetic lipoglycopeptide 71 Telik logo TELINTRA 71 pipeline GlycoPEG GCSF 71 IMPDH inhibitor 71 humanized therapeutic 71 Successfully Completes Phase 71 candidates Azedra TM 71 TELINTRA R 71 VEGFR2 inhibitor 71 PNP inhibitor 71 MKC# MT 70 Initiates Clinical 70 XOMA 3AB 70 TRIOLEX HE# APOPTONE HE# 70 Completes Patient Enrollment 70 Receives Orphan Drug Designation 70 oral prodrug 70 kidney urologic 70 ALTROPANE R 70 SinuNase ™ 70 gastro intestinal inflammation 70 Vaccine Adjuvant 70 overactive bladder AA# 70 lintuzumab SGN 70 Idera Pharmaceuticals develops 70 agonistic human 70 Auxilium transmucosal film 70 Kosan dependence 70 cladribine Cladribine Tablets 70 GVAX ® 70 4SC AG ISIN DE# 70 infectious diseases autoimmune diseases 70 developing Surfactant Replacement 70 topical antifungal product 70 receptor inhibiting monoclonal 70 accumulate preferentially 70 molecular imaging radiopharmaceutical 70 using VIAdel TM 70 selectively inhibit replication 69 novel L DOS# 69 oral dihydropyrimidine dehydrogenase DPD 69 virus HCV protease inhibitor 69 induced mucositis 69 R MSCRAMM 69 TRIOLEX ™ 69 Empatic ™ 69 modified glutathione analog 69 Civacir TM Hepatitis C 69 lead molecular radiotherapeutic 69 RNAi Therapeutic 69 JAK2 Inhibitor 69 Initiates Dosing 69 MSCRAMM ® 69 Micromet proprietary BiTE 69 NS5b 69 Veronate R 69 non porcine pancreatic 69 HCV RNA polymerase 69 SPL# Gel vaginal microbicide 69 Nicotine Conjugate Vaccine 69 sores onychomycosis nail 69 Granted Orphan Drug 69 Amgen Neulasta R 69 GlycoPEGylated hemostasis compounds 69 include Healive TM 69 CB2 selective receptor agonist 69 Initiate Phase 69 Initiates Phase 69 Submits IND 69 estrogen receptor beta agonist 69 pan histone deacetylase 69 Provectus Pharmaceuticals specializes 69 Staphylococcus aureus Immune Globulin 69 patented DepoVax TM 69 5 lipoxygenase activating 69 nano particle tumor suppressor 68 Investigational Oral 68 Acetavance TM intravenous acetaminophen 68 Inc. www.micromet inc.com 68 oral proteasome inhibitor 68 investigational pharmacologically unique 68 Pharma Merck Serono 68 Submits Response 68 HCV polymerase 68 recombinant PSMA vaccine 68 TKB# 68 attach auristatin 68 Therapeutic Competitors Companies 68 polysaccharide polymer 68 Phase 2b Clinical Trial 68 delivers fluocinolone acetonide FA 68 MCSP respectively 68 dihydrochloride Phase 3 68 Second Pivotal Phase 68 Ovitrelle R Serostim 68 oral ghrelin agonist 68 intranasal insulin product 68 THR beta agonist 68 DG# compounds targeting 68 Lenocta TM 68 SIX RO ROG 68 includes TOLAMBA TM 68 approved incretin mimetic 68 Xcytrin R 68 personalized cellular immunotherapy 68 clinical trials Archexin 68 PRN FDA Approves 68 humanized interleukin 6 68 M# rationally 68 Prochymal TM 68 novel therapeutic antibodies 68 Quinamed R 68 Presents Preclinical Data 68 CYT# vascular disrupting 68 MKC# MKC# PP 68 Hereafter Inception Iron Man 68 Bilive R combined 68 Vitrasert R 68 boxer dachshund bulldog 68 Initiates Phase III 68 NEBIDO VANTAS SUPPRELIN LA 68 Trubion proprietary 68 essential thrombocythemia ET 68 R vitespen 68 commercializing oxidized glutathione 68 ATRA IV 68 inflammatory PDE 68 Meets Primary Endpoint 68 HGS ETR1 mapatumumab 68 folate analogue metabolic 67 PEGylated docetaxel 67 Budesonide foam crofelemer 67 dasatinib Sprycel ® 67 Pruvel ™ 67 Commences Phase 67 include Alferon N 67 treats acute lymphoblastic 67 CYT# potent vascular disrupting 67 Presents Positive 67 Unanimously Recommends Approval 67 Amigal TM 67 omecamtiv mecarbil formerly 67 Namenda Memantine HCl 67 particularly SANCTURA XR 67 include Altastaph TM 67 IMiDs ® 67 INSPIRE Trial Phase III 67 clinical trials dacetuzumab SGN 67 IG HCR ;) CO 67 NASH Huntington 67 based pretargeting methods 67 novel VDA molecule 67 topical anti infective 67 CD4 monoclonal antibody 67 psoriasis rheumatoid arthritis 67 vi Immtech ability 67 Personalized Immunotherapy 67 Boehringer Ingelheim MedImmune 67 Aflibercept 67 oral nucleoside analogue 67 orally administered inhibitor 67 Files Investigational 67 Universal Pandemic Influenza 67 Completes Enrollment 67 AN# topical anti 67 investigational hepatitis B 67 Initiate Clinical Trial 67 R Saizen R 67 expanded autologous cellular 67 palonosetron hydrochloride Injection Dacogen 67 systemic RNAi therapeutic 67 systemic Phase 1b 67 MT#/MEDI-# 67 Reports Preclinical Data 67 alfimeprase direct 67 Mylan Receives Approval 67 SinuNase TM 67 CYP#A# CYP#D# 67 Receives Fast Track 67 targeted anticancer biopharmaceuticals 67 forodesine purine nucleoside phosphorylase 67 next generation URAT1 67 ALN TTR 67 novel immunotherapies 67 Achieves Primary Endpoint 67 Intermezzo ® zolpidem tartrate 67 inhalation anthrax cutaneous anthrax 67 Omigard TM omiganan pentahydrochloride 67 interferon beta 1a infertility 67 Submits NDA 67 ALN PCS 67 MT# MEDI 67 commercialize deforolimus ARIAD 67 platform HDL Mimetic 67 Receives Orphan Drug 67 albiglutide currently 67 Initiate Phase III 67 antiangiogenesis therapies 67 AN# novel 67 Merck OSI Pharmaceuticals 67 diseases bone metastasis 67 markets COLAZAL 67 Albuferon albinterferon alfa 2b 66 product candidate Lpathomab 66 Neutrolin ® 66 Hematide ™ 66 Luveris R Ovidrel R 66 toenail onychomycosis 66 Dendreon investigational 66 Oral Calcitonin 66 5 HT2A inverse 66 acetonide FA 66 TNFerade ™ 66 Unigene nasal calcitonin 66 proprietary HuCNS SC 66 Ostarine ™ 66 FDA Accepts 66 Licenses Novel 66 anti CD3 monoclonal 66 vapreotide acetate 66 selectin antagonist 66 ovarian cancer chronic hepatitis 66 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 66 recombinant subunit vaccine 66 PDX pralatrexate 66 human IgG1 monoclonal 66 Nasdaq AEGR 66 drug GLPG# 66 Kinase Inhibitor 66 GVAX R 66 delta gamma agonist 66 hepatitis C lupus 66 include Healive 66 selective A2A adenosine receptor 66 highly purified pasteurized 66 class mGluR5 inhibitor 66 dyslipidemia hypertension diabetes 66 topically applied SEPA 66 Aganocide 66 cytidine nucleoside analog 66 R sorafenib tablets 66 targeting Inflammatory Bowel 66 HCV NS5B polymerase 66 factor TNF receptor 66 Awarded Qualifying Therapeutic 66 related CMV Retinitis 66 muscarinic receptor agonist 66 BioSante Pharmaceuticals Announces 66 erlotinib Tarceva R 66 selective immunoproteasome inhibitor 66 mesylate tablets approved 66 Nasdaq MNKD focused 66 targeted immunotherapies 66 Recurrent Glioblastoma 66 TM Aganocide 66 tumor activated prodrug 66 antigen rPA anthrax 66 Submits Supplemental 66 Panzem R 66 REG2 Regado 66 HEPLISAV ™ 66 IgG1 monoclonal antibody 66 CD# CEA 66 developing Zerenex ferric 66 hypoxia activated prodrug 66 Additionally Soligenix 66 Peginterferon alfa 2b 66 PEG irinotecan 66 DNA methyltransferase inhibitors 66 IAP inhibitor 66 solid tumors ZYBRESTAT 66 commercializing dermatological products 66 investigational humanized monoclonal antibody 66 Tarmogen 66 dependent kinase inhibitor 66 KRYSTEXXA TM pegloticase 66 OMP #R# 66 Shigatoxin producing E. coli 66 markets Testim ® 66 neuropathic pain spasticity 66 LymphoStat B belimumab 66 IMiDs R 66 targeting miR 66 StaphVAX R 66 Forodesine 66 cancer indications bafetinib 66 YOUR LOCAL ANIMAL SHELTER 66 ASONEP ™ 66 Bayer HealthCare Onyx Pharmaceuticals 66 Genentech sanofi aventis 66 HYVISC ® treatment 66 personalized dendritic cell 66 FOLOTYN ® 66 adecatumumab MT# 66 Amgen Neulasta ® 66 Aeolus Pharmaceuticals Announces 66 recombinant biopharmaceutical 66 includes investigational compounds 66 Luramist TM 66 structure infections ABSSSI 66 developing oral talactoferrin 66 drug pipeline TAFA# 66 TO GUARANTEE 66 including thyroiditis RA 66 Panflu TM Sinovac 66 Augment ™ 66 investigational oral inhibitor 66 personalized dendritic 66 BY WILLA J. 66 compound ISA# 66 Initiates Phase 2b 66 RANK Ligand inhibitor 66 6 sulfatase 66 lead Aganocide compound 66 NS5B polymerase 66 lead compound ISA# 66 ® bortezomib 66 NPC 1C 66 systemic lupus erythematosus rheumatoid 66 PORxin TM platforms 66 novel antimitotic agent 66 GlaxoSmithKline Kyowa Kirin 66 NU# direct 66 sapacitabine CYC# 66 molecular chaperone regulation 65 Iluvien ® 65 AMEX KAL 65 pathophysiological effects 65 Selective Electrochemical Tumor Ablation 65 injectable investigational 65 dose intramuscular 65 Phase #b/#a clinical 65 Antibody Drug Conjugate 65 Unit Dose Budesonide 65 Announces Tentative Approval 65 Therapeutic Vaccine 65 novel orally inhaled 65 dependent cellular cytotoxicity 65 Chimigen TM 65 NicVAX TM 65 AVAX AC Vaccine 65 Simulect 65 Vitrasert ® 65 inflammatory autoimmune diseases 65 Vaccine Candidate 65 myocardial infarction ventricular fibrillation 65 anti VEGF aptamer 65 dihydrochloride Tablets 65 ZFP Therapeutics 65 Gonal f R follitropin 65 AzaSite ISV 65 novel orally administered 65 world safest multivalent 65 Zemiva TM 65 Pegloticase 65 initiated Phase Ib 65 telomerase therapeutic 65 reformulates existing FDA 65 sanofi aventis Bayer Schering 65 novel proprietary KL4 65 active cellular immunotherapy 65 Janis Joplin soundalike respiratory 65 OTCBB JMAR leading 65 MTP inhibitor 65 Sphingomab TM 65 evaluating picoplatin 65 ALN HPN 65 refractory chronic lymphocytic 65 telomerase inhibitor drug 65 secretory phospholipase A2 65 ionotropic glutamate receptor antagonists 65 methylnaltrexone bromide 65 Solazed TM 65 triciribine phosphate monohydrate 65 Sangamo ZFP TF 65 Fx #A 65 Humanized Anti 65 equine osteoarthritis marketed 65 2 methoxyestradiol 65 Enrolls First 65 Vascular Disrupting Agent 65 Civacir TM 65 pancreas esophagus 65 CDK cyclin dependent 65 PORxin TM 65 Inc. Nasdaq MITI 65 Maxy G# 65 ABLYNX 65 Aganocide ® 65 mitogen activated ERK kinase 65 TLR9 agonist IMO 65 biodefense pathogens 65 Novel Oral 65 Oral NKTR 65 non nucleoside HCV 65 compound PMX # 65 Excellarate TM 65 metastatic carcinoid 65 muscarinic receptor agonists 65 Prodarsan R 65 molecular imaging radiopharmaceuticals 65 Receives Approvable Letter 65 CEL SCI Phase III 65 candidate Lovaxin C 65 BHT DNA 65 Alvine Pharmaceuticals 65 HEPLISAV TM 65 affects cervids 65 Mg Usa 65 generation DACH Platinum 65 aldehyde dehydrogenase ALDH2 deficiency 65 OcuGene glaucoma genetic 65 By JAMAAL ABDUL 65 Phase 2b Trial 65 PANVAC VF 65 CYTEC INDUSTRIES 65 apricitabine ATC 65 introduced NEUGENE 65 sulfonylhydrazine class 65 Genentech Wyeth Pharmaceuticals 65 Immunomedics Announces 65 Locked Nucleic Acid 65 cachexia anti infectives 65 MKC# 65 albiglutide 65 VentiRx Pharmaceuticals 65 FDA APPROVES 65 products MKC# PP 65 proprietary BiTE ® 65 proprietary radiolabeled monoclonal 65 Marcus Gronholm BP 65 Nventa proprietary CoVal 65 Trial Evaluating 65 mocetinostat MGCD# 65 interferon alpha IFN 65 mighty ultraliberal establishment 65 novel emulsion formulation 65 Daclizumab 65 Liprotamase 65 intravesical infusion therapy 65 diarrhea fatigue asthenia 65 JZP 65 XmAb ® 65 cosmetic cosmeceutical products 65 NATIONAL ECONOMIC COUNCIL DIRECTOR 65 brand ciclesonide HFA 65 compound CMX# 65 oral calcitonin licensed 65 XL# XL# 65 recurrent metastatic ovarian cancer 65 alkylated amino acid 65 carcinoma mCRC 65 WHEN YOU WERE DOWN 65 OncoVex 65 negative allosteric modulator 65 dimebon latrepirdine 65 Augment TM 65 EVIZON TM squalamine lactate 65 Merck Serono Nycomed 64 Janus kinase 64 gastrointestinal stromal 64 Trofex ™ 64 TO AVOID PREGNANCY WHILE 64 SynCon ™ DNA 64 Receives Milestone Payment 64 MEDAREX 64 CTAP# 64 PEGylated Fab fragment 64 Empatic TM 64 Illusionist Toy Story 64 LymphoStat B TM 64 enhance ApoA 64 product platforms AZX# 64 involving dopaminergic degeneration 64 please visit http:/www.vandapharma.com 64 ENABLE Phase 2 64 HuCNS SC ® 64 CysDisplay R 64 MOVIPREP R 64 pan BCR ABL 64 novel tubulin binding 64 colorectal bladder 64 endoscopic autofluorescence imaging 64 Anflu TM influenza 64 signal detection CTSD 64 Perflubutane Polymer Microspheres 64 CYP#A# isoenzyme 64 novel antiviral therapeutics 64 MVA HPV IL2 64 Exherin 64 antibiotic candidate Ramoplanin 64 WHILE THE COMPANY 64 Completes Dosing 64 COLLABORATION WITH 64 proprietary intranasal insulin 64 targeted antifolate 64 R roscovitine CDK cyclin 64 HepeX B TM 64 XP# XP# 64 HuCAL PLATINUM ® CysDisplay 64 TM pralatrexate injection 64 Rosetta Genomics Nasdaq ROSG 64 Initiated Phase 64 manufactures minimally invasive 64 ABL inhibitor completing 64 Elestrin ® 64 Rigel R# 64 Inc. Amex PIP 64 XL# XL# XL# XL# 64 visit www.genenews.com 64 Zalypsis 64 OTCBB URGP specialty 64 ZFP Therapeutics applications 64 Crizotinib PF # 64 metabolism viral replication 64 STRIKE PRICE COMPARES TO 64 Hsp# Inhibitor 64 fungal infections malaria tuberculosis 64 rusalatide acetate 64 Immunotherapeutic 64 OctoPlus licensed 64 PET FROM 64 motexafin gadolinium Injection 64 developing ACAPODENE 64 Suppository Hydrocortisone Acetate Rectal 64 include PLX IBD 64 drug conjugates ADCs 64 Hematology Molecular Pathology 64 potentially treat nephropathic 64 developing KL4 surfactant 64 acetylgalactosamine 6 64 Ruined temples 64 Nasdaq XTLB 64 peptidic compound 64 Mr. Cavala manages 64 diarrhea predominant irritable 64 superparamagnetic iron oxide nanoparticles 64 rheumatoid arthritis thrombocytopenia 64 Syncria albiglutide 64 anionic backbone 64 Idera Pharmaceuticals 64 Archexin 64 P#X# antagonist 64 Epothilone D 64 OSI Eyetech specializes 64 Maribavir 64 difficile associated 64 sorafenib tablets 64 Pivotal Phase 64 progressive metastatic prostate 64 phenylalanine ammonia lyase 64 ASE SVA 64 bucindolol hydrochloride 64 treat chronic sinusitis 64 Selzentry Celsentri 64 Develop Novel 64 THAT ARE DIFFICULT TO 64 NYSE Amex YMI 64 anti PlGF 64 autologous cellular immunotherapy 64 Inc. ProMetic www.prometic.com 64 AVI BioPharma Announces 64 rotavirus shingles 64 Receive Milestone Payment 64 Ecallantide 64 CEQ# 64 ASONEP TM 64 skeletal sarcomere activators 64 candidate XP# 64 selective estrogen receptor modulator 64 read Palintologist 64 Launches Generic Version 64 BiovaxID TM 64 includes VIAtab TM 64 Cannabinor 64 Accelerated Intelligent 64 Vaccine Protects Against 64 targets Galectin receptors 64 RNAi Therapeutics 64 fibrin derived 64 cardiovascular disease autoimmune disorders 64 acting fibrinolytic 64 Potassium Chloride Sodium Ascorbate 64 Omacetaxine 64 clinical trials Archexin ® 64 TEXANS DNP 64 Anturol ® 64 candidate ATHX 64 Prednisporin 64 either acutely decompensated 64 Phase III Pivotal 64 developing ostarine selective 64 candidates Azedra 64 oral Janus kinase 64 patented DepoVax ™ 64 TBC M4 64 Ribavirin causes 64 treat musculoskeletal metabolic 64 Nasdaq ACHN 64 Demonstrates Positive 64 dacetuzumab SGN 64 Biogen Genentech 64 Nasdaq VNDA 64 clinical trials SGN 64 Bradmer Pharmaceuticals 64 DepoCyt ® Abelcet ® 64 prostate cancer antigen prostatic 64 Trastuzumab DM1 64 mild vasodilator 64 EGFr humanized monoclonal antibody 64 nasal decolonization 64 Pandemic Influenza Vaccine 64 PEG PAL PEGylated recombinant 64 Strep Staph 64 Drug Candidate 64 ONYX PHARMACEUTICALS 64 zolpidem tartrate sublingual tablet 64 Medarex logo 64 FUSILEV enhances 64 HepDirect R 64 vomiting fever headache 64 TRANSDUR ™ 64 non thiazolidinedione TZD 64 Through Glycoscience R 64 selective angiogenic kinase inhibitor 64 include GALNS N 64 XSSE OXGN 64 Valortim TM 64 nanofiltered plasma derived 64 active AKT inhibitor 64 delta opioid receptor 64 trastuzumab DM1 T DM1 64 2A receptor agonist 64 Nasdaq MNKD focuses 64 Phase Ib clinical trials 64 perifosine novel potentially 64 serious systemic Staphylococcal 64 BCG refractory carcinoma 64 Endotoxin Activity Assay 63 gastrointestinal mucositis 63 subsidiaries visit http:/www.apricusbio.com 63 immunosuppressive compound 63 R lenalidomide 63 Nasdaq AMLN Eli Lilly 63 aerosolized AAT 63 anti miRs antisense oligonucleotide 63 developing adecatumumab 63 novel topoisomerase 63 prokinetic agent 63 Phase IIb Trial 63 specific CCR9 antagonist 63 Nasdaq HALO biopharmaceutical 63 AcryMed Incorporated 63 Onalta TM 63 TNF Tumor Necrosis Factor 63 investigational protease inhibitor 63 anti atherothrombotic 63 orBec R oral beclomethasone 63 label Lipofen R 63 delivery polymer matrix 63 sarcoma melanoma 63 recombinant polyclonal antibodies 63 CIMZIA r certolizumab pegol 63 including eniluracil ADH 63 ENL recurrence 63 acyclovir Lauriad R 63 Therapies SRT 63 REMOXY POSIDUR ELADUR 63 TLR7 agonist 63 staphylococcal vaccines 63 MEK Inhibitor 63 renal failure interstitial lung 63 Kuvan TM sapropterin 63 SBIR Grant 63 investigational monoclonal antibody 63 nano particle therapies 63 Oral Solution OSMOPREP 63 develop HBV reactivation 63 topical gel formulation 63 defensin mimetic antibiotic 63 TransVax ™ 63 commercialize OncoGenex lead 63 TNF alpha selectively neutralizing 63 cathepsin K inhibitor 63 Presents Preclinical 63 AFREZZA TM 63 USP Tablets PEPCID 63 receiving chemoradiation therapy 63 Fast Track Status 63 Agonist MABA program 63 Emily Blunt shimmered 63 novel MetAP 2 63 eye socket ruptured 63 PI3K/Akt pathway inhibitor 63 PEGylated anti 63 Anidulafungin 63 CORT # estimates 63 enhanced skin permeation 63 orally inhaled migraine 63 novel synthetic PEGylated 63 vivo toxicology 63 THE UNDERLYING FUTURE 63 bladder ovarian 63 Emergent marketed 63 Panzem NCD 63 malignant infectious 63 CCR5 mAb 63 migraine headaches neuropathic pain 63 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 63 hepatitis C viral infection 63 urinary bladder wall 63 naloxol derivative 63 potently inhibit 63 Aloprim TM allopurinol sodium 63 small molecule Hedgehog 63 candidate deforolimus 63 AKT inhibitor 63 CMV vaccine 63 Myocet 63 TRANSDUR ® 63 cough nasopharyngeal pain 63 sunitinib Sutent ® 63 recombinant protective 63 HDL Mimetic Peptide 63 candidate AQ4N 63 Shiwakoti wrinkled 63 R DepoCyt 63 inhibitor PRO 63 Sirna Therapeutics StrataCom 63 lexidronam injection 63 ABL inhibitor 63 PF # [002] 63 PDE4 inhibitor 63 ASG 5ME dacetuzumab SGN 63 therapeutic monoclonal antibody 63 Therapeutic Competitors companiesandmarkets.com adEgemonye 63 Intravenous Human 63 POTELLIGENT ® Technology 63 Novartis Organon 63 KSP inhibitor 63 ocular formulation 63 Eg5 kinesin spindle 63 RAS MAPK pathway 63 Wafer polifeprosan 63 adenosine A2A 63 vaginal lidocaine product 63 Synavive ™ 63 TKM PLK1 63 ZymoGenetics intends 63 BENLYSTA TM 63 ELADUR ™ 63 SinuNase TM novel 63 5 fluorouracil leucovorin 63 5 HT2A serotonin 63 monoclonal antibody IgG1 Mab 63 compound INCB# 63 Advanced Melanoma 63 directed radiotherapeutic antibody 63 Adenoviral 63 treat nephropathic cystinosis 63 METOZOLV ™ ODT metoclopramide 63 MULLIGAN FAMILY FUN CENTER 63 GATTEX ™ 63 CDAD Clostridium difficile 63 Miraxion Amarin lead 63 orBec ® oral beclomethasone 63 histone deacetylase HDAC 63 DPX Survivac 63 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 63 lucinactant 63 BioMarin develops 63 XmAb TM 63 Viread tenofovir disoproxil fumarate 63 using Crucell PER.C6 63 STOP SHOPPING FOR 63 diets Nevius 63 NASDAQ PPHM clinical 63 include ClindaReach TM 63 Arno Therapeutics 63 Predictive medicine 63 AdVac ® 63 Hematide ™ peginesatide 63 metastatic pancreatic 63 NYSE PFE Exelon Rivastigmine 63 Vitamin D analogue 63 broad spectrum cephalosporin 63 ADCC enhanced 63 include ColorectAlert TM 63 Anflu R influenza 63 nilotinib Tasigna ® 63 Genentech Boehringer Ingelheim 63 Sodium Sulfate Sodium Chloride 63 var arrContent = 63 please visit www.medicinova.com 63 Presently DARA 63 AAG KOS 63 biomimetics non 63 Vytorin combines 63 R famotidine 63 ILUVIEN ® 63 Staphylococcus aureus Polysaccharide Conjugate 63 developing Zerenex TM 63 vaginal candidiasis 63 Emtriva Viread 63 inhibit oxidative stress 63 ARRY # 63 Darapladib 63 includes AstraZeneca Accolate 63 SIX ROG VX 63 TESTIMONY FROM 63 AGS PSCA 63 Shows Promise Against 63 cutaneous T 63 Amgen discovers develops 63 5 FU leucovorin 63 OAB overactive bladder 63 antibody MAb 63 microRNA Therapeutics 63 insomnia migraine headaches 63 Vertex hepatitis C 63 Curaxin CBLC# 63 Hematide TM 63 Recombinant Human 63 Custirsen 63 GRNOPC1 contains 63 NEWS RELEASE THE COMPANY 63 adrenergic regulation 63 Atripla combines 63 Frozen Shoulder syndrome Adhesive 63 SEA WAVES RISE 63 asthma COPD Chronic 63 psoriasis inflammatory bowel 63 beta 1a 63 Dyax Biologics License Application 63 immunotherapeutic approaches 63 comprise Alnylam RNAi 63 primarily enzymatic reactions 63 vectored vaccine 63 investigational hepatitis C 63 Hedgehog Pathway Inhibitor 63 Trofex TM 63 nucleotide analog polymerase inhibitor 63 Gentamicin Surgical Implant 63 poly ADP ribose polymerase 63 intranasal vaccines derived 63 Factor VIIa 63 influenza BCX# purine nucleoside 63 acid phosphatase PAP 63 Annamycin 63 formerly LymphoStat B 63 treatment naive genotype 63 evaluating T DM1 63 Zemiva ™ 63 treat secondary hyperparathyroidism 63 SILENOR TM doxepin HCl 63 Combination REOLYSIN R 63 please visit http:/www.sunesis.com 63 receptor tyrosine kinase inhibitor 63 SynCon TM DNA 63 trastuzumab Herceptin R 63 benzoic acid hyoscyamine sulfate 63 HEPLISAV TM hepatitis B 63 mesylate tablets fluoroquinolone antibiotic 63 SPRYCEL ® 63 antiplatelet compound 63 RH1 targeted chemotherapeutic agent 63 GALNS N acetylgalactosamine 63 Angiocept 63 candidate Hematide TM 63 Randomized Phase 63 2hours #mins #.#secs M 63 nucleotide polymerase inhibitor 63 Combivir Kivexa 63 COLAZAL R 63 INDICATED LOWER 63 Pancreate 63 Amgen discovers develops manufactures 63 include VALSTAR TM 63 investigational pan BCR 63 RON Notch 63 TransVax TM 63 humanised monoclonal antibody 63 Endologix Powerlink System 63 vaccine GMK 63 ThermoDox ® clinical 63 decreased matrix metalloproteinase 63 purified inactivated vaccine 62 Announce License Agreement 62 XmAb ™ 62 HCl PEPCID ® famotidine 62 diabetes irritable bowel 62 EOquin TM phase 62 visit www.sciclone.com 62 'S EFFORTS TO 62 molecular chaperone regulator 62 GERD migraine headaches 62 selective inverse agonist 62 pentadentate logo R 62 CTAP# Injection 62 2 Microglobulin beta 62 Darinaparsin Zinapar TM 62 Perifosine KRX 62 alfa 2a 62 * olmesartan medoxomil 62 transthyretin TTR 62 Refrigerate sliced 62 provides adenoviral reagents 62 novel histone deacetylase 62 OMAPRO ™ 62 Juvaris BioTherapeutics 62 FDA Approves Novel 62 Ep CAM 62 AcryMed technologies 62 VitiGam TM 62 Protexia ® 62 including myalgia fever 62 Familial Adenomatous Polyposis FAP 62 Enterobacter spp 62 FDA Clears 62 DOS# 62 Idenix Novartis 62 Teva Provides Update 62 AFREZZA ® 62 Cytogen marketed 62 HCV NS3 protease 62 diagnostic molecular imaging 62 Phase III multicenter 62 purinergic receptors P#X# 62 taxane derivative 62 developing Surfactant Therapies 62 dipeptidyl peptidase IV 62 IMiDs ® compound 62 carcinoid syndrome diabetes 62 Inc. Nasdaq VIAP 62 NeoLipid R 62 KL4 Surfactant 62 LEVADEX orally inhaled 62 utilizes InSite Vision 62 Staff Writer jschramm@minotdailynews.com 62 UCB www.ucb group.com 62 TBC# 62 Cardium Therapeutics TM 62 NeurogesX Nasdaq NGSX 62 submitted Biologics License 62 THE RELATIONSHIP BETWEEN 62 trodusquemine MSI 62 Zorbtive TM 62 R daptomycin 62 USHE groundbreaking pocket BLU 62 Zemiva TM Trofex TM 62 GATTEX TM 62 commercializing anti infective 62 orderonlineviagra 62 Inc. AMEX YMI 62 itraconazole Sporanox 62 rxRNA 62 Demonstrates Significant 62 HIV coinfected 62 NYSE Amex AEN 62 bleu cheese fritters 62 MorphoSys Galapagos 62 www.ucb group.com 62 Traci Arbios 62 Chimigen 62 tranquilizers diazepam 62 Bezielle 62 Dyax logo 62 PROfusion 62 selective modulator 62 phenylketonuria PKU developed